Peptide based vaccine designing against endemic causing mammarenavirus using reverse vaccinology approach
© 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature..
The rodent-borne Arenavirus in humans has led to the emergence of regional endemic situations and has deeply emerged into pandemic-causing viruses. Arenavirus have a bisegmented ambisense RNA that produces four proteins: glycoprotein, nucleocapsid, RdRp and Z protein. The peptide-based vaccine targets the glycoprotein of the virus encountered by the immune system. Screening of B-Cell and T-Cell epitopes was done based on their immunological properties like antigenicity, allergenicity, toxicity and anti-inflammatory properties were performed. Selected epitopes were then clustered and epitopes were stitched using linker sequences. The immunological and physico-chemical properties of the vaccine construct was checked and modelled structure was validated by a 2-step MD simulation. The thermostability of the vaccine was checked followed by the immune simulation to test the immunogenicity of the vaccine upon introduction into the body over the course of the next 100 days and codon optimization was performed. Finally a 443 amino acid long peptide vaccine was designed which could provide protection against several members of the mammarenavirus family in a variety of population worldwide as denoted by the epitope conservancy and population coverage analysis. This study of designing a peptide vaccine targeting the glycoprotein of mammarenavirues may help develop novel therapeutics in near future.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:206 |
|---|---|
| Enthalten in: |
Archives of microbiology - 206(2024), 5 vom: 15. Apr., Seite 217 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Chaudhuri, Dwaipayan [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Epitopes |
|---|
| Anmerkungen: |
Date Completed 16.04.2024 Date Revised 16.04.2024 published: Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1007/s00203-024-03942-4 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM371089980 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM371089980 | ||
| 003 | DE-627 | ||
| 005 | 20240416233321.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240415s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s00203-024-03942-4 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1377.xml |
| 035 | |a (DE-627)NLM371089980 | ||
| 035 | |a (NLM)38619666 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Chaudhuri, Dwaipayan |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Peptide based vaccine designing against endemic causing mammarenavirus using reverse vaccinology approach |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 16.04.2024 | ||
| 500 | |a Date Revised 16.04.2024 | ||
| 500 | |a published: Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature. | ||
| 520 | |a The rodent-borne Arenavirus in humans has led to the emergence of regional endemic situations and has deeply emerged into pandemic-causing viruses. Arenavirus have a bisegmented ambisense RNA that produces four proteins: glycoprotein, nucleocapsid, RdRp and Z protein. The peptide-based vaccine targets the glycoprotein of the virus encountered by the immune system. Screening of B-Cell and T-Cell epitopes was done based on their immunological properties like antigenicity, allergenicity, toxicity and anti-inflammatory properties were performed. Selected epitopes were then clustered and epitopes were stitched using linker sequences. The immunological and physico-chemical properties of the vaccine construct was checked and modelled structure was validated by a 2-step MD simulation. The thermostability of the vaccine was checked followed by the immune simulation to test the immunogenicity of the vaccine upon introduction into the body over the course of the next 100 days and codon optimization was performed. Finally a 443 amino acid long peptide vaccine was designed which could provide protection against several members of the mammarenavirus family in a variety of population worldwide as denoted by the epitope conservancy and population coverage analysis. This study of designing a peptide vaccine targeting the glycoprotein of mammarenavirues may help develop novel therapeutics in near future | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Glycoprotein complex | |
| 650 | 4 | |a Immunological properties | |
| 650 | 4 | |a Mammarenavirus | |
| 650 | 4 | |a Peptide vaccine | |
| 650 | 4 | |a Reverse vaccinology | |
| 650 | 7 | |a Peptides |2 NLM | |
| 650 | 7 | |a Vaccines |2 NLM | |
| 650 | 7 | |a Epitopes |2 NLM | |
| 650 | 7 | |a Glycoproteins |2 NLM | |
| 700 | 1 | |a Datta, Joyeeta |e verfasserin |4 aut | |
| 700 | 1 | |a Majumder, Satyabrata |e verfasserin |4 aut | |
| 700 | 1 | |a Giri, Kalyan |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Archives of microbiology |d 1974 |g 206(2024), 5 vom: 15. Apr., Seite 217 |w (DE-627)NLM000013242 |x 1432-072X |7 nnns |
| 773 | 1 | 8 | |g volume:206 |g year:2024 |g number:5 |g day:15 |g month:04 |g pages:217 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1007/s00203-024-03942-4 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 206 |j 2024 |e 5 |b 15 |c 04 |h 217 | ||